Q3 2022 Holdings
Filed 2022-11-14 | 217 holdings | $1.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $191.5M | 956,762 | 19.0% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $147.3M | 3,804,047 | 14.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $114.8M | 4,058,792 | 11.4% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $97.5M | 2,190,762 | 9.7% |
| Charles RIV Labs Inc(CRL) | COM | 159864107 | $51.8M | 262,993 | 5.1% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $50.6M | 1,800,000 | 5.0% |
| Caredx Inc(CDNA) | COM | 14167L103 | $44.3M | 2,601,446 | 4.4% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $42.5M | 101,818 | 4.2% |
| Centene Corp del(CNC) | COM | 15135B101 | $41.1M | 528,440 | 4.1% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $27.2M | 571,721 | 2.7% |
| Atricure Inc(ATRC) | COM | 04963C209 | $25.1M | 642,447 | 2.5% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $24.6M | 941,871 | 2.4% |
| Adaptive Biotechnologies(ADPT) | COM | 00650F109 | $23.4M | 3,279,620 | 2.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $22.2M | 496,524 | 2.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $21.4M | 2,846,457 | 2.1% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $20.7M | 153,580 | 2.1% |
| Align Technology Inc(ALGN) | COM | 016255101 | $15.5M | 74,939 | 1.5% |
| Avantor Inc(AVTR) | COM | 05352A100 | $9.9M | 503,007 | 1.0% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $8.0M | 4,717,113 | 0.8% |
| Biogen Inc(BIIB) | COM | 09062X103 | $7.7M | 28,735 | 0.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.5M | 53,493 | 0.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.5M | 71,200 | 0.3% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $2.3M | 98,100 | 0.2% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $2.3M | 16,997 | 0.2% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.2M | 83,500 | 0.2% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $940.0K | 7,000 | 0.1% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $699.0K | 66,300 | 0.1% |
| Alphabet Inc(GOOG) | CAP STK CL C | 02079K107 | $577.0K | 6,000 | 0.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $418.6K | 9,463,400 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $335.3K | 1,158,126 | 0.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $331.9K | 919,346 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $303.2K | 2,855,146 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $184.4K | 1,559,801 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $182.9K | 2,744,277 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $168.3K | 898,092 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $154.9K | 3,329,279 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $154.5K | 2,193,200 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $151.9K | 1,569,851 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $149.9K | 296,754 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $116.3K | 2,970,678 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $109.8K | 823,839 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $106.2K | 5,912,639 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $96.6K | 476,932 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $94.9K | 367,435 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $94.1K | 4,204,820 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $92.3K | 4,680,162 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $92.0K | 202,492 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $85.8K | 373,953 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $84.8K | 1,025,715 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $84.0K | 3,746,086 | 0.0% |